FDA Looking At Over $20 Million Annually In Proposed Cosmetics Fees
This article was originally published in The Rose Sheet
Executive Summary
“The Rose Sheet” offers an interactive bar graph depicting the fee schedule proposed for cosmetic registration under the Personal Care Products Safety Act for 2016, based on average gross annual sales for the preceding three-year period, as well as the percentage of targeted fee revenue for which each industry tier would be responsible in subsequent years.
You may also be interested in...
Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?
President Trump appears to want greater user-fee contributions from FDA-regulated industries to offset cuts to federal spending in fiscal 2018. His recently released budget blueprint could complicate negotiations that cosmetics stakeholders were hoping to join, but it also could signal opportunity for an industry seeking increased regulation – and willing to pay for it.
Consumers, Health Practitioners Heeded FDA’s Call For WEN-Related AEs
FDA’s safety alert in July, asking WEN users and their doctors to share information regarding hair loss-related adverse events, yielded approximately 1,000 reports in just over two months, contributing to a massive increase in cosmetic AE reports for FY 2016.
Fourth Time’s A Charm? President’s FY 2016 Budget Includes Cosmetic Fees
Continuing what has become a familiar refrain, the Obama administration’s fiscal 2016 budget request for FDA includes cosmetics user fees, marking the fourth consecutive year that such a system has been proposed. Legislation would need to be introduced – and passed – in order to establish cosmetics user fees.